Bangkok Lab And Cosmetic (BLC) Stock Overview
Manufactures and distributes pharmaceuticals and medicinal chemical products for humans and animals in Thailand, Laos, Cambodia, Hongkong, Vietnam, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
BLC Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Looking to be second time lucky with a game-changing new product
Key Takeaways Unicycive has successfully completed clinical development of its lead asset, Oxylanthanum Carbonate (OLC). OLC has been designed to improve on current phosphate binders by offering better efficacy, fewer pills, and improved tolerability over alternative treatments for hyperphosphatemia chronic kidney disease patients on dialysis.Read more
Bangkok Lab And Cosmetic Public Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ฿3.88 |
| 52 Week High | ฿5.20 |
| 52 Week Low | ฿3.38 |
| Beta | 0.54 |
| 1 Month Change | -7.18% |
| 3 Month Change | -3.00% |
| 1 Year Change | -7.18% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -46.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| BLC | TH Pharmaceuticals | TH Market | |
|---|---|---|---|
| 7D | -1.0% | -0.9% | -0.06% |
| 1Y | -7.2% | 17.1% | 21.1% |
Return vs Industry: BLC underperformed the TH Pharmaceuticals industry which returned 17.1% over the past year.
Return vs Market: BLC underperformed the TH Market which returned 21.1% over the past year.
Price Volatility
| BLC volatility | |
|---|---|
| BLC Average Weekly Movement | 2.9% |
| Pharmaceuticals Industry Average Movement | 5.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in TH Market | 9.4% |
| 10% least volatile stocks in TH Market | 2.2% |
Stable Share Price: BLC has not had significant price volatility in the past 3 months compared to the TH market.
Volatility Over Time: BLC's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | n/a | Suvit Ngampoopun | bangkoklab.co.th |
Bangkok Lab And Cosmetic Public Company Limited manufactures and distributes pharmaceuticals and medicinal chemical products for humans and animals in Thailand, Laos, Cambodia, Hongkong, Vietnam, and internationally. It distributes food supplements, cosmeceuticals, cosmetic, and pharmaceutical products; medicine, medical supplies, tonics, and supplements for animals; and supplementary food and herbs. The company also engages in provision of management consulting and logistic services; export and distribution of cosmeceuticals; wholesale and retail of modern medicines, dietary supplements, medical cosmetics, cosmetics, home remedies, herbal products, and medical devices; and the operation of direct marketing business.
Bangkok Lab And Cosmetic Public Company Limited Fundamentals Summary
| BLC fundamental statistics | |
|---|---|
| Market cap | ฿2.33b |
| Earnings (TTM) | ฿173.02m |
| Revenue (TTM) | ฿1.68b |
Is BLC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BLC income statement (TTM) | |
|---|---|
| Revenue | ฿1.68b |
| Cost of Revenue | ฿690.23m |
| Gross Profit | ฿988.37m |
| Other Expenses | ฿815.35m |
| Earnings | ฿173.02m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.29 |
| Gross Margin | 58.88% |
| Net Profit Margin | 10.31% |
| Debt/Equity Ratio | 10.8% |
How did BLC perform over the long term?
See historical performance and comparisonDividends
Does BLC pay a reliable dividends?
See BLC dividend history and benchmarks| Bangkok Lab And Cosmetic dividend dates | |
|---|---|
| Ex Dividend Date | Apr 09 2026 |
| Dividend Pay Date | Apr 30 2026 |
| Days until Ex dividend | 23 days |
| Days until Dividend pay date | 44 days |
Does BLC pay a reliable dividends?
See BLC dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/16 20:55 |
| End of Day Share Price | 2026/03/16 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bangkok Lab And Cosmetic Public Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.